Aurobindo Pharma says co, subsidiary made party to litigation proceeding in US

The drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless allegations' against the company.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2Z91NWs
via IFTTT